CRO Alliance is a contract research group consisting of 3 companies - Cross SA, Cross Research SA and Cross Pharma, each of which specialize in different clinical development activities, ranging from pre-clinical project development to phase II clinical activities. Headquartered close to Lugano in Switzerland, the group is capable of offering cost and time effective services through high quality, custom-tailored, and time-saving niche approaches. The operations, more focused to the early development and involving its own Phase I unit and selected clinical centres in most of the EU countries, are substantiated by a proven reliability, efficiency and flexibility. Cross and DATATRAK have been working in collaboration since 2004, and have performed multiple studies with sites in both the EU and US. Cross is also a Technology Transfer customer, having designed several eCRFs themselves through DATATRAK’s ASP model.

Pharm-Olam International delivers cost effective, quality clinical services to pharmaceutical, biotechnology, and medical device trials across a wide range of indications. Since 1994, Pharm-Olam has been committed to its objective: to develop and execute well-designed trials that give their sponsor's product its best chance to succeed and get it to market faster. Pharm-Olam conducts trials that allow sponsors to use an adaptive strategy. Pharm-Olam systems and processes enable very tight study management creating faster enrollment, fewer queries, fast database lock, and reduced time between studies and phases. With offices worldwide and coverage in more than 40 countries, Pharm-Olam has the resources to conduct clinical trials in established and emerging markets - from Phase I studies with unique patient populations to large, multi-national Phase III trials. This advantage allows Pharm-Olam to go further to find difficult to recruit patients.

PHT Corporation is the clear market leader provider of electronic patient reported outcome (ePRO) solutions. Its LogPad® and StudyPad® Systems are used by over 80 biopharmaceutical clients in more than 300 clinical trials worldwide in order to capture and manage high quality, timely and reliable data from patients of all ages. These data are available for real-time review by sites and sponsors using PHT’s StudyWorks™ online portal, thereby enhancing diary compliance, patient safety and trial management efficiencies. To learn more about how DATATRAK customers leverage our partnership with PHT to improve PRO data quality and conduct smaller trials, visit the new www.phtcorp.com.

Solutions

• Overview
• Datatrak Partners
• CDISC
• ASP Model
• Enterprise Program

Fast Facts

DATATRAK International, Inc.

-Cleveland, Ohio: Headquarters and  Global Data Center
-Bryan, Texas: eClinical  Development Facility

DATATRAK Deutschland GmbH

-Global Solutions Center and  Unifyer Development Team

Publicly traded: NASDAQ:DATA

Established 1995
Experience with over 230 trials
Used in over 55 countries

14 drugs received regulatory approval after using DATATRAK EDC^TM

For more information:
marketing@datatrak.net